The effect of geopolitical flux on antimicrobial resistance
- PMID: 40533604
- DOI: 10.1038/s41591-025-03758-9
The effect of geopolitical flux on antimicrobial resistance
Conflict of interest statement
Competing interests: L.S.P.M. has consulted for or received speaker fees from bioMerieux (2013-2025), Eumedica (2016–2025), Pfizer (2018–2025), Sumitovant (2021–2023), Shionogi (2021–2025), Qiagen (2023), Gilead (2024), BioNTech (2024), Insmed (2024) and Advanz (2024–2025) and received research grants from the National Institute for Health and Care Research (2013–2025), CW+ Charity (2018–2025), North West London Pathology (2022–2024), LifeArc (2020–2022), Shionogi (2024–2025), Infectopharm (2022–2024), the Joint Programming Initiative on AntiMicrobial Resistance (2023–2025) and the Healthcare Infection Society (2024–2025). S.J.C.P. has received research grants from the Drummond Foundation and the John Muir Trust and Healthcare Infection Society not in connection with this work. S.J.C.P. was a parliamentary intern to the office of Dr. Danny Chambers, MP, on behalf of the British Society for Antimicrobial Chemotherapy.
References
-
- Lekagul, A. SDG Move https://go.nature.com/45bAtMD (accessed 6 March 2024).
-
- Ho, C. S. et al. Lancet Microbe 6, 100947 (2025). - PubMed
-
- Tasker, A. J., Jones-Parr, C. A. & Richardson-Gool, T. S. Through the Kaleidoscope: Antimicrobial Resistance, Conflict and Security (Wilton Park, 2025); https://go.nature.com/4kMQKMs
-
- World Health Organization. https://go.nature.com/4jCYkbv (21 December 2023).
Publication types
LinkOut - more resources
Full Text Sources
